Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Iron Overload”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableStudy completedNCT03743272
What this trial is testing

Repeatability and Reproducibility of Multiparametric MRI

Who this might be right for
Liver DiseasesPrimary Biliary CirrhosisNon-Alcoholic Fatty Liver Disease+6 more
Perspectum 61
Testing effectiveness (Phase 2)Study completedNCT00631163
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Who this might be right for
Chronic AnemiaTransfusional Hemosiderosis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Ended earlyNCT01604941
What this trial is testing

Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell Transfusions
Shire 32
Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT01254227
What this trial is testing

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload

Who this might be right for
Cardiac Iron Overload
Novartis Pharmaceuticals 60
Not applicableUnknownNCT03293953
What this trial is testing

Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)

Who this might be right for
Liver Fibrosis
Ente Ospedaliero Ospedali Galliera 100
Post-approval studies (Phase 4)Study completedNCT07673497
What this trial is testing

Can Vitamin D Replacement Correct Chronic Disease Anemia?

Who this might be right for
Vitamin DIron Deficiency and OverloadInflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)
Gazi University 43
Post-approval studies (Phase 4)Study completedNCT00564941
What this trial is testing

Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

Who this might be right for
Myelodysplastic SyndromesBeta-Thalassemia
Novartis Pharmaceuticals 309
Not applicableStudy completedNCT05440487
What this trial is testing

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 489
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00600938
What this trial is testing

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Who this might be right for
Transfusional Iron OverloadTransfusional Hemosiderosis
Novartis Pharmaceuticals 197
Not applicableNot Yet RecruitingNCT07352878
What this trial is testing

Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

Who this might be right for
ThalassemiaIron Overload
Elpen Pharmaceutical Co. Inc. 150
Large-scale testing (Phase 3)Study completedNCT01825512
What this trial is testing

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Who this might be right for
Chronic Iron Overload
Consorzio per Valutazioni Biologiche e Farmacologiche 435
Post-approval studies (Phase 4)UnknownNCT02225886
What this trial is testing

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Who this might be right for
Anaemia Response to the TreatmentPeripheral Iron IndicesOxalemia
Anemia Working Group Romania 100
Testing effectiveness (Phase 2)Study completedNCT02125877
What this trial is testing

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Who this might be right for
Chronic Iron Overload Due to Transfusion-dependant Anemias
Novartis Pharmaceuticals 173
Large-scale testing (Phase 3)Study completedNCT02720536
What this trial is testing

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)WithdrawnNCT01927913
What this trial is testing

Treatment of Iron Overload Requiring Chelation Therapy

Who this might be right for
Transfusional Iron OverloadIron OverloadIron Chelation+4 more
Shire
Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Not applicableStudy completedNCT06215287
What this trial is testing

Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 400
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Next Page